$CRAI earnings report

Broad-based Revenue Growth Drives Company’s Best-Ever Third-Quarter Results. AlphAI read Cra International's Q3 FY2026 filing as strong. 2 quarters are on record below.

Q3 FY2026

AlphAI · Earnings readCRAI · Third quarter fiscal 2026 · ended October 3, 2026

Broad-based Revenue Growth Drives Company’s Best-Ever Third-Quarter Results

✓Strong quarter

Third-quarter revenue grew 15.6% year over year to $214.9 million, GAAP net income increased 21.2% to $13.9 million, and CRA increased its full-year constant-currency revenue guidance to $830 million to $840 million.

Revenue
$215M
15.6% y/y
EPS · non-GAAP
$2.19
6.3% y/y
Full-year fiscal 2026, on a constant currency basis relative to fiscal 2025 outlook
$830 million to $840 million

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Revenue, fiscal quarter ended October 3, 2026GAAP$214.9M–15.6%
Revenue, fiscal year-to-date period ended October 3, 2026GAAP$626.7M––
Costs of services (exclusive of depreciation and amortization), fiscal quarter ended October 3, 2026GAAP$152.4M––
Selling, general and administrative expenses, fiscal quarter ended October 3, 2026GAAP$35.41M––
Selling, general and administrative expenses, fiscal year-to-date period ended October 3, 2026GAAP$105.2M––
Depreciation and amortization, fiscal quarter ended October 3, 2026GAAP$3.24M––
Income from operations, fiscal quarter ended October 3, 2026GAAP$23,893 (in thousands), or 11.1% of revenue––
Income from operations, fiscal year-to-date period ended October 3, 2026GAAP$65,466 (in thousands), or 10.4% of revenue––
Interest expense, net, fiscal quarter ended October 3, 2026GAAP−$2.61M––
Foreign currency gains (losses), net, fiscal quarter ended October 3, 2026GAAP$59K––
Provision for income taxes, fiscal quarter ended October 3, 2026GAAP$7.44M––
Net income, fiscal quarter ended October 3, 2026GAAP$13.9 million, or 6.5% of revenue–21.2%
Net income, fiscal year-to-date period ended October 3, 2026GAAP$38,546 (in thousands), or 6.2% of revenue––
Basic earnings per share, fiscal quarter ended October 3, 2026GAAP$2.21––
Diluted earnings per share, fiscal quarter ended October 3, 2026GAAP$2.20–27.2%
Diluted earnings per share, fiscal year-to-date period ended October 3, 2026GAAP$5.98––
Non-GAAP net income, fiscal quarter ended October 3, 2026non-GAAP$13.9 million, or 6.4% of revenue–1.5%
Non-GAAP net income, fiscal year-to-date period ended October 3, 2026non-GAAP$40,824 (in thousands), or 6.5% of revenue––
Non-GAAP diluted earnings per share, fiscal quarter ended October 3, 2026non-GAAP$2.19–6.3%
Non-GAAP diluted earnings per share, fiscal year-to-date period ended October 3, 2026non-GAAP$6.33––
Non-GAAP EBITDA, fiscal quarter ended October 3, 2026non-GAAP$27.1 million, or 12.6% of revenue–11.2%
Non-GAAP EBITDA, fiscal year-to-date period ended October 3, 2026non-GAAP$77,135 (in thousands), or 12.3% of revenue––
Utilization, fiscal quarter ended October 3, 2026other78%––
Quarter-end consultant headcount, fiscal quarter ended October 3, 2026other.–6.2% year over year

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Full-year fiscal 2026, on a constant currency basis relative to fiscal 2025 outlook

  • Revenue$830 million to $840 million
  • NoteNon-GAAP EBITDA margin in the range of 12.2% to 12.8%.
  • NoteThe constant currency adjustment will decrease CRA’s reported annual revenue by approximately $2.9 million.
  • NoteThe constant currency adjustment will decrease CRA’s reported annual EBITDA by approximately $0.4 million.
  • NoteNon-cash forgivable loan amortization is expected to increase in fiscal 2026 by approximately $15 million.
  • NoteApproximately $14 million of the increase in non-cash forgivable loan amortization has been booked through the first three quarters of fiscal 2026.

Capital returns

  • CRA returned $3.6 million of capital to its shareholders via dividend payments.
  • Quarterly cash dividend increased by 17.5% from $0.57 to $0.67 per common share.
  • The $0.67 per common share dividend is payable on December 11, 2026 to shareholders of record as of November 24, 2026.
  • Cash dividends and dividend equivalents paid were $11,040 (in thousands) for the fiscal year-to-date period ended October 3, 2026, compared with $10,098 (in thousands).
  • Repurchase of common stock was $(49,303) (in thousands) for the fiscal year-to-date period ended October 3, 2026, compared with $(47,149) (in thousands).

What drove it

  • Seven practices grew year over year, representing approximately 95% of the company’s total revenue for the third quarter.
  • Forensic Services, Life Sciences, and Risk, Investigations & Analytics each posted double-digit revenue growth year over year.
  • Antitrust & Competition Economics posted a new high for quarterly revenue.
  • Legal & Regulatory offerings grew 15.7% year over year, while Management Consulting services increased 9.8%.
  • North American operations increased by 18.0% and international operations grew 6.2% year over year.
  • On a constant currency basis relative to the third quarter of fiscal 2025, revenue would have been higher by $0.3 million.

Concerns

  • Non-GAAP EBITDA margin was 12.6% of revenue in the third quarter of fiscal 2026, compared with 13.1% in the third quarter of fiscal 2025.
  • Net cash used in operating activities was $(43,910) (in thousands) for the fiscal year-to-date period ended October 3, 2026.
  • Accounts receivable and unbilled services, net were $289,574 (in thousands) at October 3, 2026.
  • Management expects non-cash forgivable loan amortization to increase in fiscal 2026 by approximately $15 million, reflecting investments in talent to drive profitable growth.
  • Fiscal 2026 returns to CRA’s typical 52-week year, whereas fiscal 2025 contained an extra week in the fourth quarter and resulted in a 53-week year.

What to watch

  • Execution against full-year constant-currency revenue guidance of $830 million to $840 million and non-GAAP EBITDA margin guidance of 12.2% to 12.8%.
  • The expected approximately $2.9 million decrease in reported annual revenue and approximately $0.4 million decrease in reported annual EBITDA from the constant currency adjustment.
  • The expected approximately $15 million increase in non-cash forgivable loan amortization, of which approximately $14 million has been booked through the first three quarters of fiscal 2026.
  • Utilization, consultant headcount growth, and the company’s healthy sales pipeline.
  • Collections and working-capital trends, given the $289,574 (in thousands) accounts receivable and unbilled services balance and $(43,910) (in thousands) of year-to-date operating cash flow.

Balance sheet and cash flow

  • Cash and cash equivalents were $20,400 (in thousands) at October 3, 2026, compared with $18,210 (in thousands) at January 3, 2026.
  • Accounts receivable and unbilled services, net were $289,574 (in thousands) at October 3, 2026, compared with $248,862 (in thousands) at January 3, 2026.
  • Revolving line of credit was $75,000 (in thousands) at October 3, 2026, compared with $34,000 (in thousands) at January 3, 2026.
  • Non-current portion of term loan was $72,923 (in thousands) at October 3, 2026, compared with $0 (in thousands) at January 3, 2026.
  • Net cash used in operating activities was $(43,910) (in thousands) for the fiscal year-to-date period ended October 3, 2026, compared with $(37,595) (in thousands).
  • Purchases of property and equipment, net were $(5,485) (in thousands) for the fiscal year-to-date period ended October 3, 2026, compared with $(2,813) (in thousands).
  • Net cash provided by financing activities was $52,096 (in thousands) for the fiscal year-to-date period ended October 3, 2026, compared with $34,891 (in thousands).

Analysis

CRA reported a record third quarter, with revenue rising 15.6% year over year to $214.9 million. GAAP net income increased 21.2% to $13.9 million and diluted earnings per share increased 27.2% to $2.20. Revenue growth was broad based: seven practices grew and represented approximately 95% of third-quarter revenue, while Legal & Regulatory grew 15.7% and Management Consulting grew 9.8%. North America grew 18.0% and international operations grew 6.2%.

Profitability improved on a GAAP basis, with income from operations of $23,893 (in thousands), or 11.1% of revenue, compared with $17,211 (in thousands), or 9.3% of revenue. However, non-GAAP EBITDA margin was 12.6% of revenue versus 13.1% a year earlier, while non-GAAP net income margin was 6.4% versus 7.3%. The quarter also included higher interest expense, net of $(2,609) (in thousands), compared with $(1,750) (in thousands).

Year-to-date revenue was $626,707 (in thousands), compared with $554,620 (in thousands), while non-GAAP EBITDA was $77,135 (in thousands), or 12.3% of revenue, compared with $72,452 (in thousands), or 13.1% of revenue. GAAP net income for the year-to-date period was $38,546 (in thousands), below $41,597 (in thousands) in the prior-year period. CRA identified portfolio optimization actions in the current year-to-date period, including $1.6 million of cash severance and $1.0 million of non-cash charges.

Cash conversion remains an important monitoring point. CRA used $(43,910) (in thousands) in operating activities year to date, versus $(37,595) (in thousands), while accounts receivable and unbilled services rose to $289,574 (in thousands). At the same time, the company repurchased $(49,303) (in thousands) of common stock and paid $11,040 (in thousands) in cash dividends and dividend equivalents. It ended the period with $20,400 (in thousands) of cash and cash equivalents, $75,000 (in thousands) on its revolving line of credit, and $72,923 (in thousands) of non-current term loan.

Management raised full-year fiscal 2026 constant-currency revenue guidance to $830 million to $840 million from the previously disclosed $805 million to $820 million range and narrowed non-GAAP EBITDA margin guidance to 12.2% to 12.8% from 12.0% to 13.0%. It expects currency to reduce reported annual revenue by approximately $2.9 million and annual EBITDA by approximately $0.4 million. CRA also raised its quarterly cash dividend 17.5% to $0.67 per common share, while flagging uncertain global macroeconomic, business, and political conditions as factors that can affect clients and the business.

Management, verbatim

CRA continues to build on its strong start to fiscal 2026 as third-quarter revenue increased 15.6% year over year to $214.9 million.

Paul Maleh, President and Chief Executive Officer

Broad-based contributions once again characterized CRA’s financial performance, reflecting both the quality and the depth of our portfolio.

Paul Maleh, President and Chief Executive Officer

Given our strong results and healthy sales pipeline, we are increasing our full-year revenue guidance and narrowing our profit margin guidance range.

Paul Maleh, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Gross margin was not reported.
  • Prior-quarter comparatives were not reported for the presented operating metrics.
  • Revenue by individual practice, Legal & Regulatory offerings, Management Consulting services, North American operations, and international operations was not reported.
  • Quarter-end consultant headcount was not reported; only the 6.2% year-over-year increase was reported.
  • Quarterly operating cash flow, quarterly capital expenditures, and free cash flow were not reported.
  • Full-year fiscal 2026 guidance for gross margin, operating expenses, tax rate, GAAP net income, GAAP earnings per share, and non-GAAP earnings per share was not reported.
  • A separate previous-release outlook was not provided; therefore, no reported actual-versus-prior-guidance comparison is included.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Q2 Fiscal 2026

AlphAI · Earnings readCRAI · Q2 Fiscal 2026 · ended July 4, 2026

Q2 fiscal 2026 revenue was $210.8 million, with GAAP operating income of $23.5 million and GAAP diluted EPS of $2.10.

✓Solid quarter

Revenue, operating income, GAAP net income, non-GAAP EBITDA, utilization and operating margin were higher than the stated Q2 fiscal 2025 comparisons, while operating cash flow was negative and revolving-credit borrowings increased.

Revenue
$211M

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
RevenueGAAP$210.8M––
Client reimbursablesGAAP$20.1 million, or 9.5% of revenue––
SG&A expensesGAAP$35.3 million, or 16.7% of revenue––
Commissions to non-employee expertsGAAPapproximately 1.3% of revenue––
SG&A expenses excluding commissionsother15.5% of revenue––
Depreciation and amortization expensesGAAP$3.3 million, or 1.6% of revenue––
Forgivable loan amortization, including performance award amortizationGAAP$14.9 million, or 7.0% of revenue––
Share-based compensation expenseGAAPapproximately $2.4 million, or 1.1% of revenue––
Operating incomeGAAP$23.5 million, or 11.2% of revenue––
Operating incomenon-GAAP$23.5 million, or 11.2% of revenue––
Net interest expenseGAAP$3.0 million, or 1.4% of revenue––
Net foreign currency lossesGAAP$0.5 million, or 0.2% of revenue––
Income before provision for income taxesGAAP$20,120, or 9.5% of revenue––
Income tax provisionGAAP$6.61M––
Effective tax rateGAAP32.9%––
Non-GAAP income before provision for income taxesnon-GAAP$20,587, or 9.8% of revenue––
Non-GAAP provision for income taxesnon-GAAP$6.72M––
Non-GAAP effective tax ratenon-GAAP32.6%––
Net incomeGAAP$13.5 million, or 6.4% of revenue, or $2.10 per diluted share––
Net incomenon-GAAP$13.9 million, or 6.6% of revenue, or $2.16 per diluted share––
Non-GAAP EBITDAnon-GAAP$26.8 million, or 12.7% of revenue––
Utilizationother77%––
Consultant headcountother968––
Adjusted net cash flows from operationsnon-GAAP$13.8M––

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Capital returns

  • CRA repurchased approximately 193,000 shares of common stock during Q2 of fiscal 2026 for $27.8 million.
  • During the fiscal quarter ended June 28, 2025, CRA repurchased approximately 231,000 shares of common stock for $43.2 million.
  • A quarterly cash dividend of $0.57 per common share, for total dividends and dividend equivalents of $3.6 million, was paid in Q2 of fiscal 2026.
  • A quarterly cash dividend of $0.49 per common share, for total dividends and dividend equivalents of $3.4 million, was paid in Q2 of fiscal 2025.

What drove it

  • Revenue was $210.8 million, compared with $186.9 million for Q2 of fiscal 2025.
  • Company-wide utilization was 77%, compared with 76% for Q2 of fiscal 2025.
  • Consultant headcount was 968, consisting of 161 officers, 581 other senior staff and 226 junior staff.
  • SG&A expenses excluding commissions were 15.5% of revenue, compared with 16.3% in Q2 of fiscal 2025.
  • Non-GAAP EBITDA was $26.8 million, or 12.7% of revenue, compared with $23.3 million, or 12.4% of revenue, for Q2 of fiscal 2025.

Concerns

  • Forgivable loan amortization, including performance award amortization, was $14.9 million, or 7.0% of revenue, compared with $10.2 million, or 5.5% of revenue, for Q2 of fiscal 2025.
  • Net interest expense was $3.0 million, compared with $1.8 million for Q2 of fiscal 2025.
  • GAAP effective tax rate was 32.9%, compared with 29.2% for Q2 of fiscal 2025.
  • Net cash used in operating activities was $4.4 million.
  • Billed and unbilled receivables were $271.7 million and DSO was 113 days at July 4, 2026.
  • Revolving credit facility borrowings were $219.0 million at July 4, 2026.

What to watch

  • Utilization and consultant headcount, including the mix of 161 officers, 581 other senior staff and 226 junior staff.
  • Forgivable loan advances, which were $19,607 in Q2 2026, and their effect on GAAP operating cash flow.
  • Billed and unbilled receivables, DSO, revolving-credit borrowings and remaining borrowing capacity.
  • Whether SG&A expenses excluding commissions remain below the Q2 fiscal 2025 level as a percentage of revenue.

Balance sheet and cash flow

  • Cash and cash equivalents was $21.4 million at July 4, 2026, compared with $19.4 million at June 28, 2025.
  • Billed and unbilled receivables at July 4, 2026 were $271.7 million, compared with $235.0 million at June 28, 2025.
  • Current liabilities at July 4, 2026 were $415.2 million, compared with $317.3 million at June 28, 2025.
  • Total Days Sales Outstanding for Q2 of fiscal 2026 was 113 days, consisting of 68 days of billed and 45 days of unbilled, compared with 110 days for Q2 of fiscal 2025, consisting of 73 days of billed and 37 days of unbilled.
  • As of July 4, 2026, there were $219.0 million in borrowings outstanding under CRA's revolving credit facility, compared with $120.0 million at June 28, 2025.
  • Revolving credit facility borrowing capacity was $77.3 million at July 4, 2026.
  • Net cash used in operating activities for Q2 of fiscal 2026 was $4.4 million, compared with net cash provided by operating activities of $5.9 million for Q2 of fiscal 2025.
  • Capital expenditures totaled $1.6 million for Q2 of fiscal 2026, compared with $1.2 million for Q2 of fiscal 2025.
  • Net cash used in investing activities was $1,646 for Q2 2026, compared with $1,189 for Q2 2025.
  • Net cash used in financing activities was $5,158 for Q2 2026, compared with $11,875 for Q2 2025.

Analysis

CRA reported Q2 fiscal 2026 revenue of $210.8 million, compared with $186.9 million in Q2 fiscal 2025. Utilization was 77%, compared with 76%, while consultant headcount was 968 versus 937. The quarter-end workforce included 161 officers, 581 other senior staff and 226 junior staff.

Profitability improved on the reported operating measures. GAAP and non-GAAP operating income were both $23.5 million, or 11.2% of revenue, compared with $19.7 million, or 10.6% of revenue. Non-GAAP EBITDA was $26.8 million, or 12.7% of revenue, compared with $23.3 million, or 12.4% of revenue. SG&A expenses excluding commissions were 15.5% of revenue, compared with 16.3%.

GAAP net income was $13.5 million, or $2.10 per diluted share, compared with $12.1 million, or $1.79 per diluted share. Non-GAAP net income was $13.9 million, or $2.16 per diluted share, compared with $12.7 million, or $1.88 per diluted share. Net interest expense rose to $3.0 million from $1.8 million, and the GAAP effective tax rate was 32.9%, compared with 29.2%.

Cash conversion and working-capital funding are the principal offsets in the disclosed results. Net cash used in operating activities was $4.4 million, while adjusted net cash flows from operations were $13,800. Forgivable loan amortization was $14.9 million, or 7.0% of revenue, and forgivable loan advances were $19,607. Billed and unbilled receivables reached $271.7 million, and DSO was 113 days.

CRA ended the quarter with $21.4 million of cash and cash equivalents, $219.0 million of revolving-credit-facility borrowings and $77.3 million of borrowing capacity. The company repurchased approximately 193,000 shares for $27.8 million and paid a quarterly cash dividend of $0.57 per common share, totaling $3.6 million. No forward guidance was included in the supplied filing text.

Not in the filing

stated, not guessed
  • Forward revenue guidance
  • Forward gross-margin guidance
  • Forward operating-expense guidance
  • Forward tax-rate guidance
  • Prior outlook for comparison
  • Segment revenue disclosure
  • Gross profit and gross margin
  • Free cash flow
  • Direct executive quotes in the supplied filing text
  • Complete adjusted net cash flows from operations table, which is truncated in the supplied filing text

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about CRAI earnings dates

When is Cra International's next earnings date?
AlphAI has no date for CRAI yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.